Just weeks into 2024 we’ve already seen the Drug Enforcement Administration confirm it is reviewing the classification of cannabis under the Controlled Substances Act, along with the first public acknowledgement of its medical use by the Department of Health and Human Services. Amid an ‘unprecedented’ situation, speculation is rife around whether the U.S. is finally heading … [Read more...] about DEA Considers Rescheduling Cannabis—What This Means For U.S. And Global Reform